(2023)
The impact of sMICA/sMICB on immunochemotherapy outcomes in newly diagnosed diffuse large B-cell lymphoma.
FRONTIERS IN ONCOLOGY.
13,
(2023)
Phase I dose escalation and expansion study of golidocitinib, a highly selective JAK1 inhibitor, in relapsed or refractory peripheral T-cell lymphomas.
ANNALS OF ONCOLOGY.
34,
11
(2023)
The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network.
BLOOD ADVANCES.
7,
17
(2023)
Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation.
FRONTIERS IN ONCOLOGY.
13,
(2023)
Retrospective analysis of diagnosis and therapeutic strategies for patients with hepatosplenic T cell lymphoma.
ANNALS OF HEMATOLOGY.
102,
7
(2023)
TET2 and LILRB1 mutations are frequent in Epstein-Barr virus-positive diffuse large B-cell lymphoma especially in elderly patients.
CANCER.
129,
10
(2023)
Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial.
BLOOD.
141,
16
(2023)
Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404).
CANCER RESEARCH AND TREATMENT.
55,
2
(2023)
Phase I Study: Safety and Efficacy of an Ex Vivo-Expanded Allogeneic Natural Killer Cell (MG4101) with Rituximab for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma.
TRANSPLANTATION AND CELLULAR THERAPY.
29,
4
(2023)
Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study.
CANCER RESEARCH AND TREATMENT.
-,
-
(2023)
Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study.
BLOOD ADVANCES.
7,
17
(2023)
Japanese subgroup analysis in the Asian phase II study of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma.
Journal of Clinical and Experimental Hematopathology.
63,
2
(2023)
Real-World Data Analysis of Survival Outcomes and Central Nervous System Relapses in Testicular Diffuse Large B Cell Lymphoma.
CANCER MANAGEMENT AND RESEARCH.
15,
(2022)
Real-World Efficacy of 5-Azacytidine as Salvage Chemotherapy for Angioimmunoblastic T-cell Lymphoma.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA.
22,
11
(2022)
Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥ 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study.
CANCER RESEARCH AND TREATMENT.
54,
4
(2022)
Survival Outcomes of Patients with Follicular Lymphoma after Relapse or Progression: A Single-Center Real-World Data Analysis.
JOURNAL OF ONCOLOGY.
2022,
(2022)
EBV-associated NK and T-cell lymphoid neoplasms.
CURRENT OPINION IN ONCOLOGY.
34,
5
(2022)
Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma.
ANNALS OF HEMATOLOGY.
101,
7
(2022)
Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts.
CANCER RESEARCH AND TREATMENT.
-,
-
(2022)
Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas.
CANCER RESEARCH AND TREATMENT.
-,
-
단행본
(2003)
중추신경계 종양.
일조각.
공동
학술회의논문
(2006)
Immunotherapy with autologous tumor lysates-pulsed dentritic cells for patients with metastatic renal cell carcinoma..
Annals of Oncology.
튀르키예
(2006)
Phase II Study od Capectabine and Cisplatin as First-line Chemotherapy in Patients with Advance Esophageal Cancer.
Cancer Research and Treatment.
대한민국
(2006)
Phase II Study of Capecitabine and Cisplatin in Advanced Biliary Tract Cancer.
Cancer Research and Treatment.
대한민국
(2006)
Pediatric-type sarcomas in adult patients: Age is an independent prognostic factor in IRS group I/II..
Cancer Research Treatment.
대한민국
(2004)
Clinical significance of insulin-like growth factor-binding protein-3 expression in advanced gastric cancer.
European journal of cancer:EORTC-NCI-AACR Conference on Molecular targets and cancer therapeutics.
스위스
(2004)
A Phase II Trial of Irinotecan, Leucovorin and 5FU Combination Chemotherapy for Metastatic AGC.
Cancer Research and Treatment.
대한민국
(2004)
Adjuvant Chemotherapy with 5-FU/Cisplatin in Patients with Regional LN (+) Thoracic Esophageal SCC.
Cancer Research and Treatment.
대한민국
(2004)
Paclitaxel and Platinum Combination in Anthra-cycline-Pretreated Metastatic Breast Cancer.
Cancer Research and Treatment.
대한민국
(2004)
Dose-intensive CHOP chemotherapy followed by radiation for localized NK/T cell lymphoma.
Journal of Clinical Oncology.
미국
(2003)
Phase II study of gemcitabine combined with uracil/tegafur (UFT) in patients with metastatic pancreatic cancer..
American Society of Clinical Oncology.
미국
(2003)
Phase II trial of weekly 24-hour infusion of gemcitabine with concurrent radiation therapy for the treatment of locally advanced pancreatic cancer..
American Society of Clinical Oncology.
미국
(2002)
Chemoradiotherapy as adjuvant therapy for gastric cancer.
Annals of Oncology.
프랑스
(2002)
Clinical Features of Primary Intestinal Lymphoma: a Review of 67 cases.
Cancer Research and Treatment.
대한민국
(2002)
A Phase II trial of adjuvant chemotherapy with 5-fluorouracil and cisplatin for patients with node positive esophageal cancer.
American Society of Clinical Oncology.
미국
(2001)
Clinical Response Achieved in AML by Manipulation of L-Ascorbic Acid (LAA) Levels..
blood (American Society of Hematology).
미국
(2001)
L-Ascorbic Acid (LAA) and Arsenic Trioxide (As2O3) Synergistically Repress Constitutive Activation of NF-kB and COX-2 Expression in Human Acute Promyelocytic Leukemia (HL-60) Cells..
Blood (American Society of Hematology).
미국
(2000)
CLINICAL RESPONSE IN ACUTE MYELOID LEUKEMIA WITH MANPULATION OF L-ASCORBIC ACID LEVEL IN VIVO TO ITS EXTREMES.
blood.
미국
(2000)
Definitive concurrent chemoradiotherapy for stage IIIB non-small cell lung cancer.
LUNG CANCER.
일본
(2000)
면역적격자에서 발생한 원발성 중추 신경계 림프종에 대한 methotrexate(MTX)를 근간으로 한 항암화학요법과 방사선 치료 복합요법의 효과.
제26회 대한암학회 학술대회.
대한민국
(2000)
전이성 대장암 환자에서 UFT-E와 경구 leucovorin 복합 항암화학요법의 제 2상 다기관 공동 임상 연구.
제26회 대한암학회 학술대회.
대한민국
